Epilepsy and inclusion in society
Why are 66% of people living with epilepsy out of work?
PharmaTimes Magazine Archive
Magazine highlights
View more from the latest edition
Diversity & Inclusion: Sarah Scanlon
Sarah Scanlon, Janssen UK, Business Unit Director, Oncology, Haematology and Cardiopulmonary
SMART PEOPLE: Thom Renwick
Thom Renwick, strategic lead for ophthalmology, Roche UK, talks to PharmaTimes about the future for UK ophthalmology and key learnings from COVID-19
Patient file: Parkinson’s Disease
David was diagnosed with Parkinson’s disease at the age of 48. He talks to PharmaTimes about his experiences with this degenerative, neurological condition
Digital catch up
Alf Goebel looks at what the pharmaceutical sector needs to do to ensure it is fit for digital purpose and takes its place at the top of the digital maturity rankings rather than hiding away at the bottom
In the real world
Modifying practices to assess pandemic-era real-world data
Cancer care in a post-COVID environment
Martin Price explores key learnings from the past 18 months
Trends, predictions and challenges for M&A activity in the life sciences sector
The industry has adapted to the COVID-19 pandemic at pace
MAGAZINE EXCLUSIVE
